GenomeWeb

rheumatoid arthritis

Jan 05, 2021

Myriad Genetics to Sell Vectra DA Business, Reorganize International Presence

The changes follow a strategic review and are part of the company's previously announced plans for growing its revenues and reducing costs.

Nov 17, 2020

PNAS Papers on Rheumatoid Arthritis Regulation, Myasthenia Gravis Thymectomy Effects, More

In PNAS this week: role of USF2 in refractory rheumatoid arthritis, thymus-associated cells may show up post-thymectomy in myasthenia gravis patients, and more.

Sep 17, 2020

Scipher Medicine Taps Ambry Genetics to Scale Up TNF Inhibitor Response Test

Ambry will provide RNA sequencing for Scipher's PrismRA blood test to predict response to TNF inhibitor therapies in rheumatoid arthritis patients.

Aug 05, 2020

Scipher Medicine to Launch PrismRA Anti-TNF Response Predictor Following Positive Data Publication

Premium

The gene expression test retrospectively identified rheumatoid arthritis patients significantly less likely to respond to TNF inhibitor therapy.

Jul 16, 2020

Rheumatoid Arthritis Flare-Up Clues Found in Blood Transcriptomes Tested Over Time

A pre-flare-up transcriptional profile in the blood led the team to a group of "pre-inflammation mesenchymal," or PRIME, cells in rheumatoid arthritis.

Jun 09, 2020

Judge Allows Whistleblower Suit Against Myriad Genetics to Proceed

Premium

In January a federal court unsealed a False Claims Act suit from an industry insider that alleges a Myriad subsidiary engaged in a fraudulent kickback scheme.

May 29, 2020

Science Papers Present Algorithm to Diagnose Slowly Progressing Diseases, Korean Genome Project

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.

Apr 16, 2020

Svar Life Science, Nimble Therapeutics Form Diagnostics Alliance

The alliance will initially focus on rheumatoid arthritis using biomarkers discovered using Nimble's human proteome immunoprofiling technology.

Feb 19, 2020

Scipher Medicine Raises Series B Financing Total to $25M

The company plans to use the funds to fuel its diagnostic development work, focused on predicting drug response in various autoimmune diseases.

Dec 19, 2019

Scipher Medicine Closes Series B Funding Round

The company has raised $30 million to date to fund development and commercialization of its molecular diagnostic test to predict response to anti-TNF therapies.

Breaking News

The Scan

Should Also Work

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

Merck Stops SARS-CoV-2 Vaccine Development

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

PLOS Papers on Rare Venous Thromboembolism Variant, Vector Mosquito LncRNAs, More

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.

Areas of Limited Testing

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

Menu